Edward Korot

Edward Korot

Auto-generated profile, based on publicly available information

Edward Korot

Retina Specialists of Michigan, Grand Rapids, Michigan

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Nature Machine Intelligence
Verified
Journal Article
Open access
PDF file
EKEdward Korot
Edward Korot
ZGZeyu Guan
Zeyu Guan
DFDaniel Ferraz
Daniel Ferraz
SWSiegfried K. Wagner
Siegfried K. Wagner
GZGongyu Zhang
Gongyu Zhang
PKPearse Keane
Pearse Keane
A number of large technology companies have created code-free cloud-based platforms that allow researchers and clinicians without coding experience to create deep learning algorithms. In this study, we comprehensively analyse the performance and featureset of six platforms, using four representative cross-sectional and en-face medical imaging datasets to create image classification models. The mean (s.d.) F1 scores across platforms for all model–dataset pairs were as follows: Amazon, 93.9 (5.4); Apple, 72.0 (13.6); Clarifai, 74.2 (7.1); Google, 92.0 (5.4); MedicMind, 90.7 (9.6); Microsoft, 88.6 (5.3). The platforms demonstrated uniformly higher classification performance with the optical coherence tomography modality. Potential use cases given proper validation include research dataset curation, mobile ‘edge models’ for regions without internet access, and baseline models against which to compare and iterate bespoke deep learning approaches.

6 May 2022 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
SNSiddharth Nath
Siddharth Nath
AMAbdullah Marie
Abdullah Marie
SESimon Ellershaw
Simon Ellershaw
EKEdward Korot
Edward Korot
PKPearse Keane
Pearse Keane
Natural language processing (NLP) is a subfield of machine intelligence focused on the interaction of human language with computer systems. NLP has recently been discussed in the mainstream media and the literature with the advent of Generative Pre-trained Transformer 3 (GPT-3), a language model capable of producing human-like text. The release of GPT-3 has also sparked renewed interest on the applicability of NLP to contemporary healthcare problems. This article provides an overview of NLP models, with a focus on GPT-3, as well as discussion of applications specific to ophthalmology. We also outline the limitations of GPT-3 and the challenges with its integration into routine ophthalmic care.

1 May 2021 in Ophthalmology
Verified
Journal Article
Open access
GMGabriella Moraes
Gabriella Moraes
DFDun Jack Fu
Dun Jack Fu
MWMarc Wilson
Marc Wilson
HKHagar Khalid
Hagar Khalid
SWSiegfried K. Wagner
Siegfried K. Wagner
RCReena Chopra
Reena Chopra
To apply a deep learning algorithm for automated, objective, and comprehensive quantification of OCT scans to a large real-world dataset of eyes with neovascular age-related macular degeneration (AMD) and make the raw segmentation output data openly available for further research. Retrospective analysis of OCT images from the Moorfields Eye Hospital AMD Database. A total of 2473 first-treated eyes and 493 second-treated eyes that commenced therapy for neovascular AMD between June 2012 and June 2017. A deep learning algorithm was used to segment all baseline OCT scans. Volumes were calculated for segmented features such as neurosensory retina (NSR), drusen, intraretinal fluid (IRF), subretinal fluid (SRF), subretinal hyperreflective material (SHRM), retinal pigment epithelium (RPE), hyperreflective foci (HRF), fibrovascular pigment epithelium detachment (fvPED), and serous PED (sPED). Analyses included comparisons between first- and second-treated eyes by visual acuity (VA) and race/ethnicity and correlations between volumes. Volumes of segmented features (mm3) and central subfield thickness (CST) (μm). In first-treated eyes, the majority had both IRF and SRF (54.7%). First-treated eyes had greater volumes for all segmented tissues, with the exception of drusen, which was greater in second-treated eyes. In first-treated eyes, older age was associated with lower volumes for RPE, SRF, NSR, and sPED; in second-treated eyes, older age was associated with lower volumes of NSR, RPE, sPED, fvPED, and SRF. Eyes from Black individuals had higher SRF, RPE, and serous PED volumes compared with other ethnic groups. Greater volumes of the majority of features were associated with worse VA. We report the results of large-scale automated quantification of a novel range of baseline features in neovascular AMD. Major differences between first- and second-treated eyes, with increasing age, and between ethnicities are highlighted. In the coming years, enhanced, automated OCT segmentation may assist personalization of real-world care and the detection of novel structure–function correlations. These data will be made publicly available for replication and future investigation by the AMD research community.

12 October 2023 in Journal of Medical Internet Research
Verified
Journal Article
Open access
ATArun James Thirunavukarasu
Arun James Thirunavukarasu
KEKabilan Elangovan
Kabilan Elangovan
LGLaura Gutierrez
Laura Gutierrez
YLYong Li
Yong Li
ITIris Tan
Iris Tan
DTDarren Shu Jeng Ting
Darren Shu Jeng Ting
Deep learning–based clinical imaging analysis underlies diagnostic artificial intelligence (AI) models, which can match or even exceed the performance of clinical experts, having the potential to revolutionize clinical practice. A wide variety of automated machine learning (autoML) platforms lower the technical barrier to entry to deep learning, extending AI capabilities to clinicians with limited technical expertise, and even autonomous foundation models such as multimodal large language models. Here, we provide a technical overview of autoML with descriptions of how autoML may be applied in education, research, and clinical practice. Each stage of the process of conducting an autoML project is outlined, with an emphasis on ethical and technical best practices. Specifically, data acquisition, data partitioning, model training, model validation, analysis, and model deployment are considered. The strengths and limitations of available code-free, code-minimal, and code-intensive autoML platforms are considered. AutoML has great potential to democratize AI in medicine, improving AI literacy by enabling “hands-on” education. AutoML may serve as a useful adjunct in research by facilitating rapid testing and benchmarking before significant computational resources are committed. AutoML may also be applied in clinical contexts, provided regulatory requirements are met. The abstraction by autoML of arduous aspects of AI engineering promotes prioritization of data set curation, supporting the transition from conventional model-driven approaches to data-centric development. To fulfill its potential, clinicians must be educated on how to apply these technologies ethically, rigorously, and effectively; this tutorial represents a comprehensive summary of relevant considerations.

4 September 2023 in Eye
Verified
Journal Article
Closed access
PDF file
MGMariana Batista Gonçalves
Mariana Batista Gonçalves
LNLuis Filipe Nakayama
Luis Filipe Nakayama
DFDaniel Ferraz
Daniel Ferraz
HFHanna Faber
Hanna Faber
EKEdward Korot
Edward Korot
RBRubens Belfort
Rubens Belfort

1 January 2016 in JAMA Ophthalmology
Verified
Journal Article
Open access
PDF file
EKEdward Korot
Edward Korot
GCGrant Comer
Grant Comer
TSTimothy Steffens
Timothy Steffens
DADavid Antonetti
David Antonetti
The incidence of diabetes mellitus is rising, with the total number of people affected worldwide projected to increase to 366 million by 2030.1 The most common cause of vision impairment in patients with diabetic retinopathy is macular edema.2 Macular edema is believed to result from a loss of the normal blood-retinal barrier with an increase in vascular permeability. It may also include impaired removal of proteins and fluid, with subsequent accumulation of fluid and cystoid formation.3,4 Vascular endothelial growth factor contributes to this process, and therapies targeting vascular endothelial growth factor have proved effective in improving visual acuity.5